Sepsis and the benefits of permissive hypoxia
Sepsis and the benefits of permissive hypoxia
批准号:
9982349
负责人:
Shahzad Shaefi
金额:
$19.39万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2023-07-31
关键词:
AcuteAdenosineAdenosine TriphosphateAdmixtureAffectAnimal ModelAntiinflammatory EffectAttentionBacterial ModelBiliverdineBindingBioenergeticsBiologicalBiological ProcessBiologyCarbon MonoxideCaringCell DeathCell HypoxiaCell physiologyCellsCessation of lifeClinicalCritical CareCritical IllnessDataDevelopment PlansDiseaseEnsureEnvironmentEquilibriumExposure toFree RadicalsFunctional disorderFundingGasesGeneral AnesthesiaGenerationsGoalsHealthHemeHemeproteinsHospitalsHyperoxiaHypoxemiaHypoxiaHypoxia PathwayImmune responseImpairmentInflammationInjuryInnate Immune ResponseIntensive Care UnitsInterventionIntuitionInvestigationIronLeadLinkMediatingMentorshipMetabolismMitochondriaMitochondrial ProteinsModelingModernizationMorbidity - disease rateMusOperating RoomsOxidative StressOxygenOxygen Therapy CarePalatePatientsPerioperative CarePharmaceutical PreparationsPlayPositioning AttributeProcessProductionProgram DevelopmentProtein GlycosylationReactive Oxygen SpeciesRecoveryResearchResolutionRoleScientistSepsisSiteStructureSupplementationTissuesTitrationsTranscendUnited StatesUp-RegulationWorkbiological adaptation to stresscareer developmentcecal ligation punctureexperiencegene productglycosylationhealth care deliveryheme oxygenase-1improved outcomeinnovationinsightmitochondrial dysfunctionmortalitymouse modelneutrophilnovelpolymicrobial sepsispre-clinicalprotective effectresponseskillsstressor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
This project proposes a five-year research career development program focused on the study of permissive
hypoxia in sepsis to expand the depth and breadth of understanding of the underlying mechanisms of
mitochondrial dysfunction in this milieu. Currently, oxygen administration is the most widely administered drug
in in-hospital care, and is liberally titrated to avoid potentially injurious periods of hypoxemia. Mounting
evidence in several allied species suggest that not only is hyperoxia detrimental, but that local tissue hypoxia
may in fact be beneficial to an evolved, requisite, and protective biological process. In critical illness such as
sepsis, mitochondrial dysfunction is common, due in large part to oxidative stress, that results in impaired ATP
generation, mitophagy, and in some cases, cell death. Strategies to mitigate or ameliorate this dysfunction and
promote decreases in morbidity and mortality are therefore sought. Delivery of exogenously delivered carbon
monoxide (CO) has stood out as a promising strategy because of its ability to simulate a protective hypoxic
pathway. CO is generated endogenously by heme oxygenase-1 (HO-1) as part of the stress response. These
molecules are potently salutary in models of sepsis and tissue hypoxia. Mechanistically, mitochondria are
principal targets for these bioactive gases, with both oxygen and CO competing for binding to the large number
of hemoproteins within the matrices. Using established models of bacterial sepsis in mice involving cecal
ligation and puncture, this project will evaluate the role of HO-1/CO in mitigating mitochondrial dysfunction
through modulation of inflammation. We will study the neutrophil where preliminary data suggest that these
cells are influenced by CO. These models will be used to characterize the host response to sepsis and how
oxygen titration affects mitochondrial function and survival. We will assess changes in mitochondrial function
and protein glycosylation signatures linked to metabolsism known to be altered during hypoxia, investigate how
mitochondria in the neutrophil are influenced by oxygen, and evaluate HO-1 and CO in promoting effective and
appropriate bacterial clearance and resolution of inflammation.
Guided by strong mentorship with significant expertise, this work has the opportunity to transcend observations
around oxygen titration in the perioperative and critical care settings. Further, this project includes a well-
structured and rigorous career development plan to build upon the candidates strong clinical and preclinical
experience. Combined with an extraordinary environment and institutional support, the successful completion
of the proposed project will provide the candidate with the skills and experience necessary to successfully
compete for funding as an independent clinician scientist, with translational expertise in an innovative research
niche.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sepsis and the benefits of permissive hypoxia
-
批准号:9806556
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2019
-
负责人:Shahzad Shaefi
-
依托单位:
Sepsis and the benefits of permissive hypoxia
-
批准号:10450186
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2019
-
负责人:Shahzad Shaefi
-
依托单位:
Sepsis and the benefits of permissive hypoxia
-
批准号:10224259
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2019
-
负责人:Shahzad Shaefi
-
依托单位:
Proteomic Analysis of Postoperative Delirium from a randomized trial in Older Patients undergoing Cardiac Surgery exposed to Intraoperative Normoxia versus Hyperoxia: A Nested Case-Control Study
-
批准号:9751173
-
项目类别:
-
资助金额:$13.13万
-
财政年份:2018
-
负责人:Shahzad Shaefi
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: